Literature DB >> 24863592

Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es study.

Sergio Valdés1, Francisca García-Torres2, Cristina Maldonado-Araque2, Albert Goday3, Alfonso Calle-Pascual4, Federico Soriguer2, Luis Castaño5, Miguel Catalá6, Ramon Gomis7, Gemma Rojo-Martínez2.   

Abstract

INTRODUCTION AND
OBJECTIVES: The aim of this study was to compare the prevalences of obesity, diabetes and other cardiovascular risk factors in the region of Andalusia with those in the rest of Spain.
METHODS: The Di@bet.es study is a national, cross-sectional, population-based survey of cardiometabolic risk factors and their association with lifestyle. The sample consisted of 5103 participants ≥ 18 years. The variables analyzed were clinical, demographic and lifestyle survey, physical examination, and oral glucose tolerance test. The prevalence of cardiovascular risk factors in Andalusia (n=1517) was compared with that for the rest of Spain (n=3586).
RESULTS: In data adjusted to the Spanish population, the prevalence of diabetes (World Health Organization, 1999), hypertension (blood pressure ≥ 140/90 mmHg), high-sensitivity CRP levels (≥ 3 mg/L) and obesity (body mass index ≥ 30 kg/m(2)) were 16.3%, 43.9%, 32.0%, and 37.0% in Andalusia compared with 12.5%, 39.9%, 28.3%, and 26.6% in the rest of Spain (P<.001 for differences except P=.01 for the difference in high-sensitivity CRP levels). The corresponding figures for the Andalusia data adjusted to the Andalusian population were 15.3%, 42.3%, 31.4%, and 34.0%, respectively. Differences in diabetes, hypertension and high-sensitivity CRP were not significant in models adjusted for age, sex, and adiposity measurements. Differences in obesity were not significant in models adjusted for age, sex, educational level, marital status, work status, and physical activity (P=.086)
CONCLUSIONS: This study contributes information from a national study perspective and shows a higher prevalence of cardiovascular risk factors in southern Spain, in close relation to obesity, a sedentary lifestyle, and markers of socioeconomic disadvantage.
Copyright © 2013 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Andalucía; Andalusia; Cardiovascular risk factors; Diabetes mellitus tipo 2; Diferencias geográficas; Epidemiology; Epidemiología; España; Factores de riesgo cardiovascular; Geographic variation; Obesidad; Obesity; Prevalence; Prevalencia; Spain; Type 2 diabetes

Mesh:

Year:  2014        PMID: 24863592     DOI: 10.1016/j.rec.2013.09.029

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  11 in total

1.  Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project.

Authors:  R J Barranco; F Gomez-Peralta; C Abreu; M Delgado; R Palomares; F Romero; C Morales; M A de la Cal; J M Garcia-Almeida; F Pasquel; G E Umpierrez
Journal:  Diabet Med       Date:  2015-08-18       Impact factor: 4.359

Review 2.  Correlation between periodontal disease management and metabolic control of type 2 diabetes mellitus. A systematic literature review.

Authors:  F-L Pérez-Losada; E Jané-Salas; M-M Sabater-Recolons; A Estrugo-Devesa; J-J Segura-Egea; J López-López
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-07-01

3.  Geographic and area-level socioeconomic variation in cardiometabolic risk factor distribution: a systematic review of the literature.

Authors:  Renin Toms; Andrew Bonney; Darren J Mayne; Xiaoqi Feng; Ramya Walsan
Journal:  Int J Health Geogr       Date:  2019-01-08       Impact factor: 3.918

4.  Geographic variation in cardiometabolic risk distribution: A cross-sectional study of 256,525 adult residents in the Illawarra-Shoalhaven region of the NSW, Australia.

Authors:  Renin Toms; Darren J Mayne; Xiaoqi Feng; Andrew Bonney
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

Review 5.  Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review.

Authors:  Sandra Martín-Peláez; Montse Fito; Olga Castaner
Journal:  Nutrients       Date:  2020-07-27       Impact factor: 5.717

6.  Recording of cardiovascular risk factors by general practitioners in patients with schizophrenia.

Authors:  Mª Carmen Castillejos; Carlos Martín-Pérez; Antonio García-Ruiz; Fermín Mayoral-Cleries; Berta Moreno-Küstner
Journal:  Ann Gen Psychiatry       Date:  2020-05-19       Impact factor: 3.455

7.  Dairy Product Consumption and Metabolic Diseases in the Di@bet.es Study.

Authors:  Ana Lago-Sampedro; Eva García-Escobar; Elehazara Rubio-Martín; Nuria Pascual-Aguirre; Sergio Valdés; Federico Soriguer; Albert Goday; Alfonso Calle-Pascual; Conxa Castell; Edelmiro Menéndez; Elías Delgado; Elena Bordiú; Luis Castaño; Josep Franch-Nadal; Juan Girbés; Felipe Javier Chaves; Sonia Gaztambide; Gemma Rojo-Martínez; Gabriel Olveira
Journal:  Nutrients       Date:  2019-01-24       Impact factor: 5.717

8.  Antihyperlipidemic and Antioxidant Effects of Averrhoa Carambola Extract in High-Fat Diet-Fed Rats.

Authors:  Saleem H Aladaileh; Sultan A M Saghir; Kisantini Murugesu; Amirin Sadikun; Ashfaq Ahmad; Gurjeet Kaur; Ayman M Mahmoud; Vikneswaran Murugaiyah
Journal:  Biomedicines       Date:  2019-09-16

9.  Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study.

Authors:  Irene Romera; Silvia Díaz; Antoni Sicras-Mainar; Flora López-Simarro; Tatiana Dilla; Esther Artime; Jesús Reviriego
Journal:  Diabetes Ther       Date:  2019-12-28       Impact factor: 2.945

10.  Andalusian program for early detection of diabetic retinopathy: implementation and 15-year follow-up of a population-based screening program in Andalusia, Southern Spain.

Authors:  Rafael Rodriguez-Acuña; Eduardo Mayoral; Manuel Aguilar-Diosdado; Reyes Rave; Beatriz Oyarzabal; Carmen Lama; Ana Carriazo; Maria Asuncion Martinez-Brocca
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.